ROCK inhibitor BDP5290, Purity ≥98%

Synonym: 1817698-21-7; BDP 5290; BDP-5290; ROCK inhibitor

Product Size

2 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BDP5290 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity. It targets MRCKα, MRCKβ, ROCK1, and ROCK2.

Molecular Weight

371.82

Molecular Formula

C₁₇H₁₈ClN₇O

Targets

MRCKα: 10 nM; MRCKβ: 100 nM; ROCK1: 5 nM; ROCK2: 50 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

BDP5290 can be used to explore ROCK inhibition for therapeutic applications in neurological disorders.

Storage

Store at -20ºC.